Diane Weiser | VP, IR & Corporate Communications |
Robert Blum | CEO, President & Director |
Fady Malik | EVP, Research & Development |
Stuart Kupfer | Chief Medical Officer |
Robert Wong | VP & CAO |
Ching Jaw | SVP & CFO |
Joe Pantginis | H.C. Wainwright |
Jason Butler | JMP Securities |
Chad Messer | Needham & Company |
Ted Tenthoff | Piper Sandler |
Jeff Hung | Morgan Stanley |
Good afternoon, and welcome ladies and gentlemen, to Cytokinetics' First Quarter 2020 Conference Call. At this time, I'd like to inform you that this call is being recorded, and that all participants are in a listen-only mode. At the company's request we will open the call for question-and-answers after the presentation.
I'll now turn the call over to Diane Weiser, Cytokinetics' Senior Vice President of Corporate Communications and Investor Relations. Please go ahead.